IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹239 Cr | ₹119 Cr | ₹93 Cr | ₹70 Cr | ₹56 Cr |
What is the latest Contingent Liabilities ratio of IPCA LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹239 Cr |
| Mar2024 | ₹119 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹70 Cr |
| Mar2021 | ₹56 Cr |
How is Contingent Liabilities of IPCA LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹239 Cr | 100.76 | |
| Mar2024 | ₹119 Cr | 27.48 | |
| Mar2023 | ₹93 Cr | 34.12 | |
| Mar2022 | ₹70 Cr | 24.95 | |
| Mar2021 | ₹56 Cr | - | |
Compare Contingent Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹38,055.0 Cr | 5.2% | -0.6% | 3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 5.2% |
-0.6% |
3% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses